Bone sialoprotein in laboratory diagnostic work-up of osteoarthritis;Sialoproteina kostna w diagnostyce laboratoryjnej choroby zwyrodnieniowej stawów

Ortopedia Traumatologia Rehabilitacja

Volumn 10, Issue 3, 2008, Pages 211-217

  Lis, Kinga ^a,b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Bone sialoprotein; Osteoarthritis; Subchondral bone

Indexed keywords

BIOCHEMICAL MARKER; BONE SIALOPROTEIN; C REACTIVE PROTEIN; CARBOXY TERMINAL TELOPEPTIDE; CARTILAGE OLIGOMERIC MATRIX PROTEIN; GLYCOPROTEIN GP 39; HYALURONIC ACID; INTERLEUKIN 6; OSTEOCALCIN; SOMATOMEDIN C; BIOLOGICAL MARKER; CARTILAGE MATRIX PROTEIN; GLYCOPROTEIN; SCLEROPROTEIN; SIALOGLYCOPROTEIN;

ARTICULAR CARTILAGE; BONE DEFECT; BONE METABOLISM; BONE TISSUE; CARTILAGE DEGENERATION; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; LABORATORY DIAGNOSIS; OSTEOARTHRITIS; PROTEIN SYNTHESIS; REVIEW; SENSITIVITY AND SPECIFICITY; SYNOVIUM; ANIMAL; BONE; CARTILAGE; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; CARTILAGE; EXTRACELLULAR MATRIX PROTEINS; GLYCOPROTEINS; OSTEOARTHRITIS; SIALOGLYCOPROTEINS;

EID: 54049095940     PISSN: 15093492     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Friedrich MJ. Kroki w kierunku zrozumienia i złagodzenia choroby zwyrodnieniowej stawów beda pomocne dla starzejacej sie populacji. JAMA 1999;282:1023-5.
2. Wollheim FA. Bone sialoprotein - a new marker for subchondral bone. Osteoarthritis Cartilage 1999;7:331-2.
3. Franzen A, Heinegard D. Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J 1985;232:715-24
4. Oldberg A, Frazen A, Heinegard D. The primary structure of cell binding bone sialoprotein. J Biol Chem 1988;263:430-2.
5. Chenu C, Ibaraki K, Gehron Robey P, Delmas PD, Young MF. Cloning and sequence analysis of bovine bone sialoprotein cDNA: conservation of acidic domains, tyrosine sulfation consensus repeats, and RGD cell attachment domain. J Bone Miner Res 1994;9:417-21.
6. Nakamura I, Rodan GA, Duongle T. Regulatory mechanism of osteoclast activation. J Electron Microsc 2003;52:527-33.
7. Gorski JP, Wang A, Lovitch D, Law D, Powell K, Midura RJ. Extracellular bone acidic glycoprotein-75 defines condensed mesenchyme regions to be mineralized and localizes with bone sialoprotein during intramembranous bone formation. J Biol Chem. 2004 11;279:25455-63.
8. Fisher LW, McBride OW, Termine JD, Young MF. Human bone sialoprotein. Deduced protein sequence and chromosomal localization. J Biol Chem. 1990 5;265:2347-51.
9. Chen Y, Bal BS, Gorski JP. Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone. J Biol Chem. 1992 5;267:24871-8.
10. Hunter GK, Goldberg HA. Nucleation of hydroxyapatite by bone sialoprotein. Proc Nat Acad Sci 1993; 90:8562-5.
11. Ganss B, Kim RH, Sodek J. Bone sialoprotein. Crit Rev Oral Biol Med 1999;10:79-98.
12. Young-Min SA, Cawston TE, Griffiths ID. Markers of joint destruction: principles, problems, and potential. Ann Rheum Dis 2001;60:545-8.
13. Haima P. Biochemical markers for the management of rheumatoid arthritis and osteoarthritis. A review of novel biomarkers of cartilage synthesis and degradation for clinical and pre-clinical use. Osteomedical Group, Clinical and Technical Monograph. [on-line periodical/periodyk on-line] 2002 [accessed /cytowany 2007.06.14] dostepny pod adresem/ available at http://www.teco-medical.ch/downloads/pdf/ Cartilage_MONO_e.pdf
14. Wieland HA, Michaelis M, Kirschbaum BJ, Rudolphi KA. Osteoarthritis - an untreatable disease? Nature Rev Drug Discovery, 2005;4:331-45.
15. Poole AR. Biochemical/immunochemical biomarkers of osteoarthritis: utility for prediction of incident or progressive osteoarthritis. Rheum Dis Clin North Am 2003;29:803-18.
16. Lis K, Odrowaz-Sypniewska G, Nowacki W. Ocena steżenia IGF-1 w surowicy krwi i płynie stawowym u kobiet ze zmianami zwyrodnieniowymi stawu biodrowego o różnej etiologii. Chir Narzadow Ruchu Ortop Pol 2005;70:407-10.
17. Lis K, Sypniewska G, Nowacki W. IGF-1, Cytokines and Bone Turnover in Osteoarthritis. Biochemia Medica 2006;16:127-36.
18. Martel-Pelletier J, Di Battista JA, Lajeunesse D, Pelletier JP. IGF/ IGFBP axis in cartilage and bone in osteoarthritis pathogenesis. Inflamm Res 1998;47:90-100.
19. Sypniewska G, Lis K, Bilinski PJ. Bone turnover markers and cytokines in joint fluid. Analyses in 10 patients with loose hip prosthesis and 39 with coxarthrosis. Acta Orthop Scand 2002;73:518-22.
20. Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D, Saxne T. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 2005;64:196-201.
21. Otterness IG, Swindell AC, Zimmerer RO, Poole AR, Ionescu M, Weiner E. An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline. Osteoarthritis Cartilage. 2000;8:180-5.
22. Lohmander LS, Felson D. Can we identify a 'high risk' patient profile to determine who will experience rapid progression of osteoarthritis? Osteoarthritis Cartilage 2004;12 Suppl A:S49-52.
23. Felson D. An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin North Am 2004;42:1-9.
24. Karmatschek M, Maier I, Seibel MJ, Woitge HW, Ziegler R, Armbruster FP. Improved purification of human bone sialoprotein and development of a homologous radioimmunoassay. Clin Chem 1997;43:2076-82.
25. Withold W, Armbruster FP, Karmatschek M, Reinauer H. Bone sialoprotein in serum of patients with malignant bone diseases. Clin Chem 1997;43:85-91.
26. Seibel MJ, Woitge HW, Pecherstorfer M, Karmatschek M, Horn E, Ludwig H, Armbruster FP, Ziegler R. Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease. J Clin Endocrinol Metab 1996;81:3289-94.
27. Shaarawy M, Hasan M. Serum bone sialoprotein: a marker of bone resorption in postmenopausal osteoporosis. Scand J Clin Lab Invest, 2001;61:513-51.
28. Carlinfante G, Vassiliou D, Svensson O, Wendel M, Heinegard D, Andersson G. Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma. Clin Exp Metastasis 2003;20:437-44.
29. Chen J, Rodriguez JA, Barnett B, Hashimoto N, Tang J, Yoneda T. Bone sialoprotein promotes tumor cell migration in both in vitro and in vivo models. Connect Tissue Res 2003;44 Suppl 1:279-84.
30. Detry C, Waltregny D, Quatresooz P, Chaplet M, Kedzia W, Castronovo V, Delvenne P, Bellahcene A. Detection of bone sialoprotein in human (pre)neoplastic lesions of the uterine cervix. Calcif Tissue Int 2003;73:9-14.
31. Fassbender WJ, Ruf T, Kaiser HE, Stracke H. Serum levels of immunoreactive bone sialoprotein in osteoporosis: positive relations to established biochemical parameters of bone turnover. In Vivo 2000;14:619-24.
32. Acabes C, de la Piedra C, Traba ML, Seibel MJ, Garcia MC, Armas J, Herrero-Beaumont G. Biochemical markers of bone remodeling and sialoprotein in aknylosing spondylitis. Clin Chim Acta 1999;289: 99-110
33. Mattei JP, Roux H. New potential therapeutic goals: subchondral bone and progression of osteoarthritis. Osteoarthritis Cartilage 1999;7:329-30.
34. Buckland-Wright C. Subchondral bone changes in hand and knee osteoarthritis detected by radiography. Osteoarthritis Cartilage 2004;12 SupplA: 63-8.
35. Felson DT, Neogi T. Osteoarthritis: is it a disease of cartilage or bone? Arthritis Rheum 2004;50:341-4.
36. Petersson IF, Boegard T, Svensson B, Heinegard D, Saxne T. Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. Br J Rheumatol 1998;37:46-50.
37. de Bri E, Lei W, Reinholt FP, Mengarelli-Widholm S, Heingard D, Svensson O. Ultrastructural immunolocalization of bone sialoprotein in guinea-pig osteoarthritis. Osteoarthritis Cartilage 1997;5:387-93.
38. Larsson E, Mussener A, Heinegard D, Klareskog L, Saxne T. Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis. Br J Rheumatol 1997;36:1258-61.
39. Petersson IF, Boegard T, Dahlstrom J, Svensson B, Heinegard D, Saxne T. Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis. Osteoarthritis Cartilage 1998;6:33-9.
40. Ekman S, Skioldebrandt E, Heinegard D, Hultenby K. Ultrastructural immunolocalisation of bone sialoprotein in the osteocartilagenous interface of the equine third carpal bone. Equine Vet J 2005;7:26-30.
41. Conrozier T, Saxne T, Fan CS, Mathieu P, Tron AM, Heinegard D, Vignon E. Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study. Ann Rheum Dis 1998;57:527-32.
42. Mansson B, Geborek P, Saxne T. Cartilage and bone macromolecules in knee joint synovial fluid in rheumatoid arthritis: relation to development of knee or hip joint destruction. Ann Rheum Dis 1997;56:91-6.
43. Saxne T, Zunino L, Heinegard D. Increased release of bone sialoprotein into fluid reflects tissue destruction in rheumatoid arthritis. Arthritis Rheum 1995;38:82-90.
44. Lohmander LS. Saxne T, Heinegard D. Increased concentrations of bone sialoprotein in joint fluid after knee injury. Ann Rheum Dis 1996;55:622-66.